Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy

被引:151
作者
Tang, AM
Forrester, J
Spiegelman, D
Knox, TA
Tchetgen, E
Gorbach, SL
机构
[1] Tufts Univ, Sch Med, Dept Family Med & Community Hlth, Div Nutr & Infect, Boston, MA 02111 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[4] Tufts Univ New England Med Ctr, Div Gastroenterol, Boston, MA USA
[5] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
weight loss; HIV-related wasting; mortality; fat-free mass; body cell mass; fat mass;
D O I
10.1097/00126334-200210010-00014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Weight loss and wasting have long been established as strong predictors of mortality in HIV-infected patients. Today, despite the effectiveness of highly active antiretroviral therapy (HAART), there is evidence that HIV-related wasting is still an important comorbidity in many patients. We conducted a study to determine if wasting is still associated with decreased survival in patients receiving HAART and which parameter (weight, fat-free mass [FFM], body cell mass [BCM], or fat mass [FM]) is most strongly associated with mortality. The study population consisted of 678 HIV-positive participants enrolled in the Nutrition for Healthy Living study. Weight, FFM, BCM, and FM were assessed for all participants at 6-month intervals. At each follow-up visit, percent losses of each parameter were calculated from values at baseline and the previous visit. Cox proportional hazards models were used to estimate and compare the relative risks of death for each parameter, adjusting for potential confounders such as HAART use, body mass index, and CD4(+) cell counts. In analyses examining the parameters separately and together in the same model, weight loss emerged as the strongest independent predictor of mortality. Weight loss of greater than or equal to10% from baseline or the previous visit was significantly associated with a four- to sixfold increase in mortality compared with maintenance or gaining of weight. Even one episode of weight loss of greater than or equal to3% from baseline or greater than or equal to5% from the previous visit was predictive of mortality. In summary, despite the apparent benefits of HAART use on HIV-related survival, weight loss remains an independent predictor of mortality. In addition, FFM or BCM estimated using bioelectrical impedance analysis does not add further prognostic value over weight loss.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 22 条
[1]  
[Anonymous], 1996, Am J Clin Nutr, V64, p524S, DOI 10.1093/ajcn/64.3.524S
[2]   Effect of indinavir on HIV-related wasting [J].
Carbonnel, F ;
Maslo, C ;
Beaugerie, L ;
Carratt, F ;
Wirbel, E ;
Aussel, C ;
Gobert, JG ;
Girard, PM ;
Gendre, JP ;
Cosnes, J ;
Rozenbaum, W .
AIDS, 1998, 12 (14) :1777-1784
[3]  
CHLEBOWSKI RT, 1989, AM J GASTROENTEROL, V84, P1288
[4]   BODY FAT ASSESSED FROM TOTAL-BODY DENSITY AND ITS ESTIMATION FROM SKINFOLD THICKNESS - MEASUREMENTS ON 481 MEN AND WOMEN AGED FROM 16 TO 72 YEARS [J].
DURNIN, JVGA ;
WOMERSLEY, J .
BRITISH JOURNAL OF NUTRITION, 1974, 32 (01) :77-97
[5]   FLEXIBLE REGRESSION-MODELS WITH CUBIC-SPLINES [J].
DURRLEMAN, S ;
SIMON, R .
STATISTICS IN MEDICINE, 1989, 8 (05) :551-561
[6]   Body composition and dietary intake in relation to drug abuse in a cohort of HIV-positive persons [J].
Forrester, JE ;
Woods, MN ;
Knox, TA ;
Spiegelman, D ;
Skinner, SC ;
Gorbach, SL .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 :S43-S48
[7]   Weight and body composition in a cohort of HIV-positive men and women [J].
Forrester, JE ;
Spiegelman, D ;
Woods, M ;
Knox, TA ;
Fauntleroy, JM ;
Gorbach, SL .
PUBLIC HEALTH NUTRITION, 2001, 4 (03) :743-747
[8]  
Hellerstein MK, 1999, AM J CLIN NUTR, V70, P787
[9]   MAGNITUDE OF BODY-CEL-MASS DEPLETION AND THE TIMING OF DEATH FROM WASTING IN AIDS [J].
KOTLER, DP ;
TIERNEY, AR ;
WANG, J ;
PIERSON, RN .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 50 (03) :444-447
[10]  
Kotler DP, 1996, AM J CLIN NUTR, V64, P489